The Aptamers Market research report offers an in-depth analysis of the global Aptamers Market by presenting details about the latest product launches and recent innovations in the market. It also provides data about the impact on the market growth due to COVID-19. The competitive landscape has also been incorporated into the market so as to understand the market's current scenarios and trends. Moreover, the report also highlights collaborations, company mergers, and upcoming collaborations to strive in the market successfully.
Aptamers, by Product Type (DNA, RNA, XNA), Technology (SELEX), Application (Therapeutics, Diagnostics, R&D), End Users (Pharmaceutical and biotechnology Companies, Academic and government Research Institutes, CROs), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America)
Aptamers Market Overview
The global Aptamers market size is projected to reach USD 343 million by 2026 at a CAGR of 17.8% from USD 151 million in 2021 during the forecast period 2021-2028.
Request Research Sample Pages: https://www.delvens.com/get-free-sample/aptamers-market-trends-forecast-till-2028
Aptamers are single-stranded oligonucleotides that have the ability to fold themselves and bind to a specific protein. This ability of binding to desired protein enables them for therapeutic use where their binding ability is exploited to inhibit protein-protein interactions. They provide an advantage over antibodies as the aptamer generation is relatively easier than the production of antibodies and is significantly cheaper as well.
With the surge in number of conducted clinical trials along with the increased awareness of advantages of aptamer over antibodies are some of the factors that have supported long-term expansion for Aptamers.
The COVID-19 pandemic which is an infectious disease led to increased R&D in the sector for enabling the use of aptamers in diagnostic kits for virus detection. An example for the development and use could be the highly specialised aptamer for spike protein of COVID-19 which was developed by NeoVentures Biotechnology.
Aptamers Market Regional Analysis
Asia Pacific is expected to be the largest market of aptamers due to the recent R&D on aptamers along with the need of the development of aptamer-based products. Amongst Asia pacific North America is expected to have the largest share of the market which is attributed to the increased financial investment in the sector.
Aptamers Market Key players
· Aptamer Group
· Aptamer Sciences Inc.
· Raptamer Discovery Group
· SomaLogic Inc.
· Aptagen LLC
· Maravai Lifesciences
· Kaneka Corporation
· NeoVentures Biotechnology Inc.
· Aptus Biotech
· Base Pair Biotechnologies
· AMSBIO
· Novaptech
· Bio-Techne
To Grow Your Business Revenue, Make an Inquiry Before Buying at: https://www.delvens.com/Inquire-before-buying/aptamers-market-trends-forecast-till-2028
Recent Developments in The Aptamers Market
· In July 2021, Korean government selected Aptamer Sciences, Inc. to support a non-clinical project for the development of a new drug and vaccine for COVID-19 and is entitled to receive a research grant of about USD 0.51 million for an year.
· In August 2021, Aptamer Group partnered with ProAxsis Limited. As per the partnership, Aptamer Group will develop validated Optimer ligands against critical targets for ProAxsis’s diagnostic assays.
· In August 2021, Aptamer Group, Ltd along with BizCom Japan, Inc. entered into a distribution and marketing agreement.
Reasons to Acquire Aptamers Market Report
· Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends and factors
· Gain authentic and granular data access for Aptamers so as to understand the trends and the factors involved behind changing market situations
· Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
· In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns
Table of Contents
Aptamers is segmented into Product Type, Technology, Application, End Users and geography.
On the basis of Type
DNA Aptamers
XNA Aptamers
RNA Aptamers
On the basis of Technology
SELEX
Others
On the basis of Application
Therapeutics Development
Research & Development
Diagnostic
Others
On the basis of Region
Asia Pacific
North America
Europe
South America
Middle East & Africa
On the basis of End-User
Pharmaceutical & Biotechnology Companies
Academic & Government Research Institutes
CROs
Others
Get Direct Order of this Report: https://www.delvens.com/checkout/aptamers-market-trends-forecast-till-2028
Browse Related Reports:
Pendred Syndrome (PS) Market – Trends Forecast Till 2030
Pendred Syndrome (PS) Market by Treatment (Cochlear Implant, Hearing Aids, and Radioactive Iodine) Route of Administration (Oral, Implantation), Diagnosis (Genetic Testing, Perchlorate Washout Test, and Others), End- Users (Hospitals, Homecare, Specialty Clinics, Otolaryngologist, and Others) and region (North America, Europe, Asia-Pacific, Middle East and Africa and South America).
Plastic Surgery and Integumentary System Market – Trends Forecast Till 2030
Plastic Surgery and Integumentary System Procedures Market, By Procedure (Prefilled Syringe Biopsy, Excisional Biopsy, Incisional Biopsy, Culture and Sensitivity (CandS), Skin Tests), Operating Areas (Eyelids, Breast), Application (Allografts, Autografts, Infections), End-Users (Hospital, Clinics) and region (North America, Europe, Asia-Pacific, Middle East and Africa and South America).
Pain Relief Gel Market – Trends Forecast Till 2030
Global Pain Relief Gel Market, By Therapeutic Class (Non-Opioids, Opioids), Type (Prescription Pain Relief, Over-the-Counter Pain Relief), Distribution Channel (Pharmacies & Drug Stores, e-Commerce, Retail & Grocery Stores) and region (North America, Europe, Asia-Pacific, Middle East and Africa and South America).
About Us:
Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports, and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on the country, regional, and global business environment. We have a database for more than 45 industries globally in more than 115+ major countries.
Delvens database assists clients by providing in-depth information on crucial business decisions. Delvens offers significant facts and figures across various industries: Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, and Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.
Contact Us:
UNIT NO. 2126, TOWER B,
21ST FLOOR ALPHATHUM
SECTOR 90 NOIDA 201305, IN
+44-20-8638-5055
French (Français)
Spanish (Español)
Arabic
Portuguese (Português)
Deutsch
Turkish (Türk)
Dutch (Nederlands)
Italiano
Romaian (Română)
Português (Brasil)
Greek (Ελληνικά)
Russian (русский)